Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Anti-Aging
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Varicella vaccine could be effective zoster prophylactic for older patients
Stanford, Calif. - Use of an inactivated varicella vaccine may prevent immunocompromised patients from developing varicella-zoster virus infection for up to a year, Ann Arvin, M.D., said. She and colleagues published a recent study in the New England Journal of Medicine showing up to 20 percent fewer patients who were varicella seropositive developed zoster a year after a hematopoietic cell transplant.
Related Videos
Related Content
